Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study)
Completed · Not applicable
Conditions studied: Obesity
In brief
Puberty represents a critical period in terms of metabolic health. Racial differences in insulin dynamics, reproductive maturation, and the associated endocrine changes may affect a female's health later in life. Further, the peripubertal period is likely the period of racial divergence in adiposity noted between European American (EA) and African American (AA) girls. Diet is a major modifiable risk factor. The identification of simple, cost-effective dietary strategies for prevention and management of metabolic disease and excess fat mass accrual during the peripubertal period is a priority. Modification of the diet to affect metabolic and endocrine outcomes with and without weight loss during the pubertal transition represents a novel approach to the pediatric obesity epidemic. It is likely that the two diets used in this project will have different metabolic effects, including effects on postprandial glycemia, triglyceride concentration, free fatty acid concentration, and satiety. These factors may in turn, affect development of metabolic perturbations, especially in susceptible individuals (e.g. AA peripubertal girls).The role of carbohydrates on metabolic outcomes, particularly among children, has received little attention. It has been hypothesized that higher postprandial glycemia may be a mechanism for disease progression. Development of a diet that reduces insulin secretion and optimizes metabolic-endocrine health among peripubertal girls will likely reduce obesity and related co-morbidities and future reliance on pharmacologic treatments, even in the absence of weight loss. However, in light of the current trends in pediatric obesity, a safe and effective regimen that also promotes weight loss is needed for the pediatric population. This proposal is significant in that it will shed light on whether diet composition, as a part of a eucaloric (weight-stable) or hypocaloric diet (weight-loss) can influence the hyperinsulinemic characteristic of AA peripubertal girls. Existing data suggest that elevated concentrations of insulin and/or reproductive hormones may contribute to the fat mass accrual in AA and could elevate risks for development of chronic diseases in adulthood. The results of this study will lead to the development of dietary means for the reduction of insulin, and thereby to the prevention of both pediatric obesity and type 2 diabetes.
Key facts
- Study ID
- NCT01410643
- Run by
- University of Alabama at Birmingham
- People needed
- 92
- Starts
- 2011-03-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2019-11-25
Who can join
Age: 7 and older, up to 11. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Self-identified as African American or European American
- Aged 7-11 AND Tanner stage < 3
- Overweight (BMI percentile 85-97th)
- Not taking any medication known to affect body composition
- No prior diagnosis of chronic condition
You may not qualify if…
- Illness that precludes study participation
- Prescribed medication known to affect body composition
- Not of EA or AA racial/ethnic group
- Obese (BMI% > 97th) or normal weight (BMI% < 85th)
- Reproductively mature as define by Tanner stage > 3
Where it is running
- UAB — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.